Published in J Biol Chem on January 15, 1987
Novel tool for the study of cholecystokinin-stimulated pancreatic enzyme secretion. J Clin Invest (1989) 1.04
Structural basis of cholecystokinin receptor binding and regulation. Pharmacol Ther (2008) 0.95
Insulation of a G protein-coupled receptor on the plasmalemmal surface of the pancreatic acinar cell. J Cell Biol (1995) 0.92
The biochemical characterization of the native pancreatic cholecystokinin receptor using affinity labeling approaches. Yale J Biol Med (1993) 0.75
P-element-mediated enhancer detection: a versatile method to study development in Drosophila. Genes Dev (1989) 5.76
The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J Infect Dis (1985) 4.08
P-element-mediated enhancer detection: an efficient method for isolating and characterizing developmentally regulated genes in Drosophila. Genes Dev (1989) 3.45
Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface. J Clin Invest (1987) 3.40
Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies. J Immunol (1986) 3.35
Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis. J Exp Med (1984) 3.14
Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy. Neurology (2012) 2.56
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Leukocyte adhesion receptors are stored in peroxidase-negative granules of human neutrophils. J Exp Med (1987) 2.33
The Drosophila sloppy paired locus encodes two proteins involved in segmentation that show homology to mammalian transcription factors. Genes Dev (1992) 2.24
Regulated expression of the Mac-1, LFA-1, p150,95 glycoprotein family during leukocyte differentiation. J Immunol (1986) 2.21
cDNA cloning and complete primary structure of the alpha subunit of a leukocyte adhesion glycoprotein, p150,95. EMBO J (1987) 2.06
Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology (1991) 1.98
Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. J Urol (1997) 1.98
Chemoattractant-regulated mobilization of a novel intracellular compartment in human neutrophils. Science (1987) 1.91
The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) alpha subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B. J Biol Chem (1988) 1.87
Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci U S A (1992) 1.77
Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology (1998) 1.73
Expression of vascular endothelial growth factor receptors in human prostate cancer. Urology (1999) 1.71
Use of N,O-bis-Fmoc-D-Tyr-ONSu for introduction of an oxidative iodination site into cholecystokinin family peptides. Int J Pept Protein Res (1988) 1.54
Sensory modulation dysfunction in children with attention-deficit-hyperactivity disorder. Dev Med Child Neurol (2001) 1.49
Relationship between native and recombinant cholecystokinin receptors: role of differential glycosylation. Pancreas (1996) 1.46
Takayasu's arteritis in Crohn's disease. Gastroenterology (1979) 1.44
Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am J Physiol (1997) 1.44
Regulation of lateral mobility and cellular trafficking of the CCK receptor by a partial agonist. Am J Physiol (1999) 1.43
Abnormal gallbladder motility in irritable bowel syndrome: evidence for target-organ defect. Am J Physiol (1991) 1.41
Coordinating inpatient and outpatient treatment for a chronically suicidal woman. Hosp Community Psychiatry (1989) 1.39
p150,95, the third member of the Mac-1, LFA-1 human leukocyte adhesion glycoprotein family. J Immunol (1986) 1.37
Sensory-modulation disruption, electrodermal responses, and functional behaviors. Dev Med Child Neurol (1999) 1.37
Dysmotility of the small intestine in irritable bowel syndrome. Gut (1988) 1.36
Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer. Gastroenterology (2001) 1.35
Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J Biol Chem (2001) 1.34
Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors. Gastroenterology (1998) 1.33
Dual pathways of internalization of the cholecystokinin receptor. J Cell Biol (1995) 1.33
Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors. J Biol Chem (1995) 1.28
Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. Am J Physiol (1994) 1.27
Dyspepsia, antral motor dysfunction, and gastric stasis of solids. Gastroenterology (1980) 1.27
Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Mol Pharmacol (1997) 1.27
Postconcussion syndrome occurs in children. Neuropsychology (1997) 1.22
Differentiation of myeloid cells is accompanied by increased levels of pp60c-src protein and kinase activity. Proc Natl Acad Sci U S A (1986) 1.21
Purification and alpha subunit N-terminal sequences of human Mac-1 and p150,95 leukocyte adhesion proteins. J Immunol (1987) 1.21
GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci (1990) 1.20
Direct identification of a distinct site of interaction between the carboxyl-terminal residue of cholecystokinin and the type A cholecystokinin receptor using photoaffinity labeling. J Biol Chem (1997) 1.16
Multiple extracellular loop domains contribute critical determinants for agonist binding and activation of the secretin receptor. J Biol Chem (1996) 1.16
Identification and localization of cholecystokinin-binding sites on rat pancreatic plasma membranes and acinar cells: a biochemical and autoradiographic study. J Cell Biol (1983) 1.14
Intrinsic photoaffinity labeling of native and recombinant rat pancreatic secretin receptors. Gastroenterology (1993) 1.13
Molecular cloning and functional expression of the human gallbladder cholecystokinin A receptor. Biochem Biophys Res Commun (1993) 1.12
Preparation and characterization of a probe for the cholecystokinin octapeptide receptor, N alpha (125I-desaminotyrosyl)CCK-8, and its interactions with pancreatic acini. J Biol Chem (1981) 1.10
Dysfunctions of the stomach with gastric ulceration. Dig Dis Sci (1980) 1.09
Gastrointestinal hormone profile in renal insufficiency. Mayo Clin Proc (1979) 1.08
Lysis of inducer T cell clones by activated macrophages and macrophage-like cell lines. J Exp Med (1983) 1.07
Gut-thyroid interrelationships. Gastroenterology (1978) 1.06
Human interdigestive and postprandial gastrointestinal motor and gastrointestinal hormone patterns. Dig Dis Sci (1982) 1.05
Demonstration of a direct interaction between residue 22 in the carboxyl-terminal half of secretin and the amino-terminal tail of the secretin receptor using photoaffinity labeling. J Biol Chem (1999) 1.05
Pancreatic exocrine function in severe human chronic renal failure. Gut (1982) 1.04
Novel tool for the study of cholecystokinin-stimulated pancreatic enzyme secretion. J Clin Invest (1989) 1.04
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger". J Med Chem (1996) 1.03
Effect of ethanol on cholecystokinin-stimulated zymogen conversion in pancreatic acinar cells. Am J Physiol (1996) 1.02
Biosynthesis and glycosylation of p150,95 and related leukocyte adhesion proteins. J Immunol (1987) 1.00
Sensitivities of human jejunum, ileum, proximal colon, and gallbladder to cholecystokinin octapeptide. Am J Physiol (1987) 0.99
Expression of cholecystokinin A receptors in neurons innervating the rat stomach and intestine. Gastroenterology (1999) 0.99
Direct identification of a second distinct site of contact between cholecystokinin and its receptor. J Biol Chem (1998) 0.99
Agonist-regulated phosphorylation of the pancreatic cholecystokinin receptor. J Biol Chem (1991) 0.98
Cholecystectomy and gastric ulcer--an etiologic relationship? Mayo Clin Proc (1980) 0.98
Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis. J Pharmacol Exp Ther (1998) 0.97
Intestinal control of human postprandial gastric function: the role of components of jejunoileal chyme in regulating gastric secretion and gastric emptying. Gastroenterology (1981) 0.97
Analysis of the carbohydrate composition of the pancreatic plasmalemmal glycoprotein affinity labeled by short probes for the cholecystokinin receptor. J Biol Chem (1987) 0.96
Purinoceptor-coupled Cl- channels in mouse heart: a novel, alternative pathway for CFTR regulation. J Physiol (1999) 0.96
Cytokines in human breast cancer: IL-1alpha and IL-1beta expression. Oncol Rep (1999) 0.96
Isolation and characterization of rat cholangiocyte vesicles enriched in apical or basolateral plasma membrane domains. Biochemistry (1995) 0.95
Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probe. J Biol Chem (2000) 0.95
Characterization of cAMP-dependent protein kinase activation by CCK in rat pancreas. FEBS Lett (1993) 0.95
Polarized expression of G protein-coupled receptors and an all-or-none discharge of Ca2+ pools at initiation sites of [Ca2+]i waves in polarized exocrine cells. J Biol Chem (2001) 0.94
Febrile convulsions in families: findings in an epidemiologic survey. Clin Pediatr (Phila) (1966) 0.94
In the absence of nutrients, pancreatic-biliary secretions in the jejunum do not exert feedback control of human pancreatic or gastric function. J Lab Clin Med (1980) 0.94
Role of receptor phosphorylation in desensitization and internalization of the secretin receptor. J Biol Chem (1996) 0.93
Hepatic processing of cholecystokinin peptides. I. Structural specificity and mechanism of hepatic extraction. Am J Physiol (1986) 0.93
Intrinsic photoaffinity labeling probes for cholecystokinin (CCK)-gastrin family receptors. D-Tyr-Gly-[Nle28,31,pNO2-Phe33)CCK-26-33). J Biol Chem (1988) 0.93
Stress-induced inhibition of sexual behavior: corticosterone inhibits courtship behaviors of a male amphibian (Taricha granulosa). Horm Behav (1984) 0.92
Insulation of a G protein-coupled receptor on the plasmalemmal surface of the pancreatic acinar cell. J Cell Biol (1995) 0.92
Identification of an interaction between residue 6 of the natural peptide ligand and a distinct residue within the amino-terminal tail of the secretin receptor. J Biol Chem (1999) 0.92
Altered sensitivity of the gallbladder to cholecystokinin octapeptide in irritable bowel syndrome. Am J Physiol (1987) 0.91
Culture of human neoplastic gastrointestinal smooth muscle cells. In Vitro Cell Dev Biol (1989) 0.91
Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update. Drug Saf (1992) 0.90
Giant hypertrophic gastropathy (Ménétrier's disease): pharmacologic effects on protein leakage and mucosal ultrastructure. Gastroenterology (1982) 0.90
Identification of two pairs of spatially approximated residues within the carboxyl terminus of secretin and its receptor. J Biol Chem (2000) 0.89
Control of human postprandial pancreatic exocrine secretion: a function of the gastroduodenal region. Dig Dis Sci (1979) 0.89
Arginine vasotocin induces sexual behavior of newts by acting on cells in the brain. Peptides (1983) 0.89
Establishment of a new short, protease-resistant, affinity labeling reagent for the cholecystokinin receptor. Biochem Biophys Res Commun (1987) 0.88
Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs. Br J Pharmacol (2014) 0.88
Multiple kinases phosphorylate the pancreatic cholecystokinin receptor in an agonist-dependent manner. Am J Physiol (1993) 0.88
The Zollinger-Ellison syndrome. A collective surgical experience. Ann Surg (1992) 0.88
Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide. J Clin Endocrinol Metab (1983) 0.87
Adenocarcinoma of the rectum arising in a hamartomatous polyp in a patient with Peutz-Jeghers syndrome. Dig Dis Sci (1983) 0.87
Crohn's disease involving the esophagus and colon. Case report. Mayo Clin Proc (1977) 0.86
Use of a nitrotryptophan-containing peptide for photoaffinity labeling the pancreatic cholecystokinin receptor. Biochemistry (1989) 0.86
A role for cholecystokinin-stimulated protein tyrosine phosphorylation in regulated secretion by the pancreatic acinar cell. J Biol Chem (1993) 0.86
Compulsive compliance in a young maltreated child. J Am Acad Child Adolesc Psychiatry (1998) 0.86
Control of cholecystokinin receptor dephosphorylation in pancreatic acinar cells. J Biol Chem (1993) 0.85